New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
Estimated read time 1 min read
Posted in Medicine

New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses

admin

  • 4th interim analysis of PEARL real world migraine prevention study presented at 10th European Association of Neurology (EAN) congress in Helsinki

  • New sub-analysis of PEARL data highlights potential negative impact of treatment pauses on patient outcomes1

  • Sub-analysis exploring impact of treatment…

[ad_2]

Source link

You May Also Like

More From Author

Video: Psychosis 25th Anniversary Recap

Video: Psychosis 25th Anniversary Recap

Most Americans don’t know that primary care physicians can prescribe addiction treatment

Most Americans don’t know that primary care physicians can prescribe addiction treatment

Leave a Reply

Your email address will not be published. Required fields are marked *